Mascoma Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 646 |
|
|
2022
Q4 | – | Sell |
-292
| Closed | -$9K | – | 642 |
|
|
2022
Q3 | $9K | Hold |
292
| – | – | ﹤0.01% | 414 |
|
|
2022
Q2 | $16K | Hold |
292
| – | – | 0.01% | 367 |
|
|
2022
Q1 | $16K | Hold |
292
| – | – | 0.01% | 392 |
|
|
2021
Q4 | $16K | Hold |
292
| – | – | 0.01% | 356 |
|
|
2021
Q3 | $14K | Buy |
+292
| New | +$14K | 0.01% | 320 |
|
|
2021
Q2 | – | Sell |
-292
| Closed | -$13K | – | 247 |
|
|
2021
Q1 | $13K | Buy |
+292
| New | +$13K | 0.01% | 325 |
|
|
2019
Q3 | – | Sell |
-482
| Closed | -$24K | – | 192 |
|
|
2019
Q2 | $24K | Hold |
482
| – | – | 0.02% | 216 |
|
|
2019
Q1 | $25K | Sell |
482
-460
| -49% | -$23.9K | 0.02% | 207 |
|
|
2018
Q4 | $45K | Sell |
942
-260
| -22% | -$12.4K | 0.03% | 147 |
|
|
2018
Q3 | $60K | Sell |
1,202
-100
| -8% | -$4.99K | 0.04% | 151 |
|
|
2018
Q2 | $66K | Hold |
1,302
| – | – | 0.05% | 135 |
|
|
2018
Q1 | $64K | Sell |
1,302
-768
| -37% | -$37.8K | 0.04% | 133 |
|
|
2017
Q4 | $96K | Sell |
2,070
-1,712
| -45% | -$79.4K | 0.06% | 112 |
|
|
2017
Q3 | $192K | Hold |
3,782
| – | – | 0.13% | 75 |
|
|
2017
Q2 | $204K | Sell |
3,782
-160
| -4% | -$8.63K | 0.14% | 71 |
|
|
2017
Q1 | $208K | Sell |
3,942
-104
| -3% | -$5.49K | 0.15% | 59 |
|
|
2016
Q4 | $195K | Buy |
+4,046
| New | +$195K | 0.14% | 65 |
|